Exelixis Inc (EXEL)

33.82 +0.34 (+1.02%) USD  |  NASDAQ  |  Dec 24, 16:00
More

Exelixis Free Cash Flow Per Share (Annual)

Free Cash Flow Per Share (Annual) Chart

View Free Cash Flow Per Share (Annual) for EXEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Annual) Range, Past 5 Years

View Free Cash Flow Per Share (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Annual) Benchmarks

View Free Cash Flow Per Share (Annual) Benchmarks
Start Trial
Merck & Co Inc Upgrade
ADMA Biologics Inc Upgrade
Alnylam Pharmaceuticals Inc Upgrade
Pfizer Inc Upgrade
Sarepta Therapeutics Inc Upgrade